ArticleJACC. Advances2026
Zero Coronary Artery Calcium as a Marker of Vascular Resilience in High-Risk Adults.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtherosclerotic cardiovascular disease (ASCVD) prevention relies on risk estimation. Yet among adults labeled high risk by the Pooled Cohort Equations (≥20%), coronary heart disease (CHD) event rates vary, with some experiencing few events, raising the possibility of a resilient phenotype.
objectivesThis study aimed to investigate whether a coronary artery calcium (CAC) score of zero identifies a resilient lower-risk group among adults with high calculated ASCVD risk and compare their risk factor profiles with those with non-zero CAC.
methodsWe analyzed participants in the Multi-Ethnic Study of Atherosclerosis with Pooled Cohort Equations-estimated ASCVD risk ≥20% and CAC data. Baseline characteristics were compared using standardized mean differences. Ten-year CHD events were analyzed using Kaplan-Meier methods, with HRs for CAC = 0 vs CAC >0 estimated using Cox models adjusted for age, sex, and race/ethnicity. Effect modification by age and sex was assessed.
resultsAmong 1,608 adults (mean age 73.2 years, 61.4% men) with ASCVD risk ≥20%, 359 (22.3%) had CAC = 0. Risk factors were similar between CAC groups, with standardized mean differences <0.20 for blood pressure, lipids, diabetes, and body mass index. Over 10 years, hard CHD incidence rates were 3.52 and 13.46 per 1,000 person-years for CAC = 0 and CAC >0, respectively. CAC = 0 was associated with lower CHD risk (HR: 0.27; 95% CI: 0.15-0.49). A significant CAC × age interaction (P = 0.023) indicated stronger protection at older ages.
conclusionsNearly one-quarter of adults labeled high ASCVD risk had CAC = 0 and accrued few events despite similar risk factor burden. CAC = 0 may mark a resilient phenotype warranting targeted mechanistic investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.